Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Levonorgestrel IUS + Everolimus for Endometrial Cancer
Recruiting1 awardPhase 2
Indianapolis, Indiana
This trial is testing whether a levonorgestrel-releasing intrauterine system, which is a type of progesterone-releasing device, is more effective when used with everolimus, a common drug used to prevent cell growth, in treating patients with atypical hyperplasia or stage IA grade 1 endometrial cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.